GenerationAll

Summary

GenerationAll aims to make advanced molecular testing widely available. This study hopes to show that advanced molecular testing can help with management and treatment of cancer patients.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 99

Inclusion criteria:

GenerationAll is a research study that welcomes participation from cancer patients with:

Advanced cancers

Incurable cancers

Cancers with a high risk of recurrence.

Adult patients (at least 18), and men and women can take part.

Patients will consent to:

Advanced molecular testing of their cancer

Advanced molecular testing of their DNA (saliva, cheek swab, skin or other biopsy)

Provide blood samples.

Patients may be contacted for participation in other or future research studies

Participate

This study is not currently accepting expressions of interest via the website. Please see contact information below.

Additional information

Contact information

Recruitment is mainly expected through oncologist referral

Principal investigator:

Etienne Mahe

Clinical trial:

No

REB-ID:

HREBA.CC-25-0347